Immuneering Corp (IMRX) Insider Trading

Immuneering Corp (IMRX) has 2 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $11K. Most recent filing: July 17, 2026.

Filings
2
Purchases
1
$11K
Sales
0
$0
Insiders
2

Most active IMRX insiders

Zeskind Benjamin J.
PRESIDENT AND CEO
1 bought · 0 sold · June 24, 2026
$11K
Gengos Andrew
Chief Financial Officer
0 bought · 0 sold · July 17, 2026
$0

Latest IMRX Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
July 17, 2026 filed July 16, 2026 Gengos Andrew Chief Financial Officer $0 650,000 0% No
June 24, 2026 filed June 23, 2026 Zeskind Benjamin J. PRESIDENT AND CEO +$10,948 2,400 +0% No

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when IMRX insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free